Skip to main content

Client News

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

13th April 2023

Rentschler Biopharma appoints Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation

12th April 2023

ONWARD to attend upcoming scientific and investor events

12th April 2023

InflaRx announces pricing of $40 Million public offering of ordinary shares

11th April 2023

InflaRx announces public offering of ordinary shares

11th April 2023

Carbios presents its 2022 annual results and the progress of its industrial and commercial deployment

6th April 2023

AiCuris AG announces appointment of Larry Edwards as Chief Executive Officer and formation of U.S. subsidiary

5th April 2023

InflaRx receives FDA emergency use authorization for Gohibic (vilobelimab) for treatment of critically Ill COVID-19 patients

5th April 2023

Abivax appoints Marc de Garidel as Chief Executive Officer and interim Board Chair

5th April 2023

Heidelberg Pharma presents new preclinical data from its proprietary ATAC technology platform at AACR Annual Meeting 2023

4th April 2023